VitaNova Life Sciences Corporation (VNOV)
OTCMKTS · Delayed Price · Currency is USD
1.380
0.00 (0.00%)
Apr 20, 2026, 12:00 PM EST

VitaNova Life Sciences Cash Flow Statement

Millions USD. Fiscal year is May - Apr.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Net Income
-0.040.850.14-0.020.14
Stock-Based Compensation
0.1800--
Provision & Write-off of Bad Debts
0.06----
Other Operating Activities
-0.020---0.15
Change in Accounts Receivable
0.48-1.27---
Change in Inventory
-0.060.09-0.13--
Change in Accounts Payable
0.21-0.010.010.01-
Change in Income Taxes
-0.180.220.06--
Change in Other Net Operating Assets
0.180.3-0.46-0.02
Operating Cash Flow
0.810.19-0.38-0.020
Operating Cash Flow Growth
322.47%----

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Short-Term Debt Issued
--000.02
Total Debt Issued
--000.02
Short-Term Debt Repaid
--0---
Total Debt Repaid
--0---
Net Debt Issued (Repaid)
--0000.02
Issuance of Common Stock
--0.96--
Financing Cash Flow
--00.9600.02

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Net Cash Flow
0.810.190.58-0.010.02

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Free Cash Flow
0.810.19-0.38-0.020
Free Cash Flow Growth
322.47%----
Free Cash Flow Margin
26.92%7.24%-65.86%-48.35%3.38%
Free Cash Flow Per Share
0.100.02-0.11-0.010.00
Levered Free Cash Flow
0.870.09-0.39-0.01-
Unlevered Free Cash Flow
0.870.1-0.39-0.01-

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Cash Income Tax Paid
0.24--0-
Change in Working Capital
0.63-0.66-0.520.010.02